Global and Japan Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2015-2026)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Regions
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Market Size
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2015-2020)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2019
3.5 Key Players Small Molecule Targeted Cancer Therapy Area Served
3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type (2015-2026)
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2021-2026)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application (2015-2026)
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2015-2020)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
8.2 China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
8.3 China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
8.4 China Small Molecule Targeted Cancer Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
9.2 Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
9.3 Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
9.4 Japan Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2015-2026)
10.2 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020))
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Details
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.2.5 Cytokinetics Inc. Recent Development
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Details
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.3.5 Hospira Inc. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.5.5 Boehringer Ingelheim GmbH Recent Development
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Details
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.6.5 Bayer HealthCare AG Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020)
11.7.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Small Molecules
Table 5. Key Players of Small Molecule Drug Conjugates
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Small Molecule Targeted Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2015-2020)
Table 10. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Table 12. Small Molecule Targeted Cancer Therapy Market Market Trends
Table 13. Small Molecule Targeted Cancer Therapy Market Drivers
Table 14. Small Molecule Targeted Cancer Therapy Market Challenges
Table 15. Small Molecule Targeted Cancer Therapy Market Restraints
Table 16. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2015-2020)
Table 18. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019)
Table 19. Global Small Molecule Targeted Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size Share by Type (2015-2020)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 26. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2015-2020)
Table 27. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application (2021-2026)
Table 29. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 31. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 37. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 39. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 41. China Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 42. China Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 43. China Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 44. China Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 45. China Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million) (2015-2020)
Table 46. China Small Molecule Targeted Cancer Therapy Market Share by Region (2015-2020)
Table 47. Japan Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 49. Japan Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 51. Japan Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 53. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Type (2015-2020)
Table 55. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Small Molecule Targeted Cancer Therapy Market Share by Country (2015-2020)
Table 59. OncoGenex Pharmaceuticals, Inc. Company Details
Table 60. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 61. OncoGenex Pharmaceuticals, Inc. Product
Table 62. OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 63. OncoGenex Pharmaceuticals, Inc. Recent Development
Table 64. Cytokinetics Inc. Company Details
Table 65. Cytokinetics Inc. Business Overview
Table 66. Cytokinetics Inc. Product
Table 67. Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 68. Cytokinetics Inc. Recent Development
Table 69. Hospira Inc. Company Details
Table 70. Hospira Inc. Business Overview
Table 71. Hospira Inc. Product
Table 72. Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 73. Hospira Inc. Recent Development
Table 74. GlaxoSmithKline plc Company Details
Table 75. GlaxoSmithKline plc Business Overview
Table 76. GlaxoSmithKline plc Product
Table 77. GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 78. GlaxoSmithKline plc Recent Development
Table 79. Boehringer Ingelheim GmbH Company Details
Table 80. Boehringer Ingelheim GmbH Business Overview
Table 81. Boehringer Ingelheim GmbH Product
Table 82. Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 83. Boehringer Ingelheim GmbH Recent Development
Table 84. Bayer HealthCare AG Company Details
Table 85. Bayer HealthCare AG Business Overview
Table 86. Bayer HealthCare AG Product
Table 87. Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 88. Bayer HealthCare AG Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2015-2020) (US$ Million)
Table 93. Abbott Laboratories Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Small Molecules Features
Figure 4. Small Molecule Drug Conjugates Features
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 6. Lymphoma Case Studies
Figure 7. Melanoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Other Cancers Case Studies
Figure 12. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Small Molecule Targeted Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Share by Regions (2021-2026)
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2019
Figure 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2019
Figure 19. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 47. Cytokinetics Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 48. Hospira Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 50. Boehringer Ingelheim GmbH Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 51. Bayer HealthCare AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 52. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed